Research Article

Comparison of 99mTc-HMPAO-labeled leukocyte scintigraphy findings with systemic inflammatory markers

Volume: 4 Number: 4 August 30, 2023
TR EN

Comparison of 99mTc-HMPAO-labeled leukocyte scintigraphy findings with systemic inflammatory markers

Abstract

Aims: Technetium-99m-hexamethylpropylene amine oxime (99mTc-HMPAO) labeled leukocyte scintigraphy is frequently used for infection imaging. The systemic immune-inflammation index is a new marker. In this study, we aim to investigate the relationship between 99mTc-HMPAO-labeled leukocyte scintigraphy findings and systemic inflammatory markers such as Neutrophil/lymphocyte ratios (NLR) and Platelet lymphocyte ratio (PLR) and systemic immune-inflammation index (SII). Methods: Patients who underwent 99mTc-HMPAO-labeled leukocyte scintigraphy between 2014 and 2020 due to suspected infection such as diabetic foot infection or prosthesis infection vs. in any part of the body were included in our study. In addition, a negative control group consisting of 19 normal subjects who had no leukocyte scintigraphy and had hemogram examination was added to the study. Cases with findings consistent with infection in labeled leukocyte scintigraphy and infectious symptoms in this area of involvement in the clinical examination were considered as the positive group. The data were evaluated with the SPSS 23.0 program. Results: Our study included 36 patients (28 males,8 females, mean age: 59.7). The mean SII was 1526±787 x109 cells/L in patients with positive findings in leukocyte scintigraphy that might be compatible with infection, while it was 1025 ± 370 x109 cells/L in patients who did not (p=0.017). The mean PLR was 183.95±68.30 in patients with positive findings in leukocyte scintigraphy that might be compatible with infection, while it was 145.81±58.30 in patients who did not (p=0.102). The mean NLR was 4.82±1.91 in patients with positive findings on leukocyte scintigraphy that might be compatible with infection, while it was 4.15±1.40 in patients who did not (p=0.181). While the negative control group and the patients who were considered positive in leukocyte scintigraphy were compared; a statistically significant difference was found between SII, NLR and PLR values. When the relationship between SII was evaluated, the mean SII was 1526±787 x109 cells/L in patients with involvement that may be compatible with infection in leukocyte scintigraphy, while it was 762±224 x109 cells/L in the negative control group (p<0.05). While the relationship between PLR was evaluated, the mean PLR was 183.95±68.30 in patients with involvement that might be compatible with infection in leukocyte scintigraphy, while it was 100.67±26.18 in the negative control group (p<0.05). When the relationship between NLR was evaluated, the mean NLR was 4.82±1.91 in patients with involvement that might be compatible with infection in leukocyte scintigraphy, while it was 3.11±0.85 in the negative control group (p<0.05). Conclusion: When labeled leukocyte scintigraphy and systemic inflammatory markers were compared, there was a statistically significant relationship between the presence of infection in scintigraphy and SII, but the relationship with NLR and PLR were not statistically significant. When the negative control group and the patients who were considered positive in leukocyte scintigraphy were compared; a statistically significant difference was found between SII, NLR and PLR values. For this reason, we think that SII, NLR and PLR may be useful markers for diagnosis confirmation in centers that can’t perform radiolabeled infection imaging.

Keywords

References

  1. Ziessman HA, O’Malley JP, Thrall JH. (2013). Nuclear medicine: the requisites e-book. Elsevier Health Sciences.
  2. Signore A, Jamar F, Israel O, Buscombe J, Martin-Comin J, Lazzeri E. Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline. Eur J Nucl Med Mol Imaging. 2018;45(10):1816-1831. doi:10.1007/s00259-018-4052-x
  3. Love C, Marwin SE, Tomas MB, et al. Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J Nucl Med. 2004;45(11):1864-1871.
  4. Palestro CJ. Radionuclide imaging of osteomyelitis. Semin Nucl Med. 2015;45(1):32-46. doi:10.1053/j.semnuclmed.2014.07.005
  5. Datz FL. Indium-111-labeled leukocytes for the detection of infection: current status. Semin Nucl Med. 1994;24(2):92-109.
  6. Yaylali O. The role of molecular imaging methods in orthopedic prosthetic infections/Ortopedik protez enfeksiyonlarinda molekuler görüntüleme yöntemlerinin rolü. Nuclear Medicine Seminars. Vol. 2. No. 2. Galenos Yayinevi Tic. Ltd., 2016.
  7. Velasco Á, Rodríguez-Revuelta J, Olié E, et al. Neutrophil-to-lymphocyte ratio: a potential new peripheral biomarker of suicidal behavior. Eur Psychiatry. 2020;63(1):e14. doi:10.1192/j.eurpsy.2019.20
  8. Sun H, Que J, Peng Y, et al. The neutrophil-lymphocyte ratio: a promising predictor of mortality in coronary care unit patients - a cohort study. Int Immunopharmacol. 2019;74:105692. doi:10.1016/j.intimp.2019.105692

Details

Primary Language

English

Subjects

Nuclear Medicine, Health Care Administration

Journal Section

Research Article

Publication Date

August 30, 2023

Submission Date

June 2, 2023

Acceptance Date

August 18, 2023

Published in Issue

Year 2023 Volume: 4 Number: 4

APA
Ertürk, S. A., & Hasbek, Z. (2023). Comparison of 99mTc-HMPAO-labeled leukocyte scintigraphy findings with systemic inflammatory markers. Journal of Medicine and Palliative Care, 4(4), 329-335. https://doi.org/10.47582/jompac.1307746
AMA
1.Ertürk SA, Hasbek Z. Comparison of 99mTc-HMPAO-labeled leukocyte scintigraphy findings with systemic inflammatory markers. J Med Palliat Care / JOMPAC / jompac. 2023;4(4):329-335. doi:10.47582/jompac.1307746
Chicago
Ertürk, Seyit Ahmet, and Zekiye Hasbek. 2023. “Comparison of 99mTc-HMPAO-Labeled Leukocyte Scintigraphy Findings With Systemic Inflammatory Markers”. Journal of Medicine and Palliative Care 4 (4): 329-35. https://doi.org/10.47582/jompac.1307746.
EndNote
Ertürk SA, Hasbek Z (August 1, 2023) Comparison of 99mTc-HMPAO-labeled leukocyte scintigraphy findings with systemic inflammatory markers. Journal of Medicine and Palliative Care 4 4 329–335.
IEEE
[1]S. A. Ertürk and Z. Hasbek, “Comparison of 99mTc-HMPAO-labeled leukocyte scintigraphy findings with systemic inflammatory markers”, J Med Palliat Care / JOMPAC / jompac, vol. 4, no. 4, pp. 329–335, Aug. 2023, doi: 10.47582/jompac.1307746.
ISNAD
Ertürk, Seyit Ahmet - Hasbek, Zekiye. “Comparison of 99mTc-HMPAO-Labeled Leukocyte Scintigraphy Findings With Systemic Inflammatory Markers”. Journal of Medicine and Palliative Care 4/4 (August 1, 2023): 329-335. https://doi.org/10.47582/jompac.1307746.
JAMA
1.Ertürk SA, Hasbek Z. Comparison of 99mTc-HMPAO-labeled leukocyte scintigraphy findings with systemic inflammatory markers. J Med Palliat Care / JOMPAC / jompac. 2023;4:329–335.
MLA
Ertürk, Seyit Ahmet, and Zekiye Hasbek. “Comparison of 99mTc-HMPAO-Labeled Leukocyte Scintigraphy Findings With Systemic Inflammatory Markers”. Journal of Medicine and Palliative Care, vol. 4, no. 4, Aug. 2023, pp. 329-35, doi:10.47582/jompac.1307746.
Vancouver
1.Seyit Ahmet Ertürk, Zekiye Hasbek. Comparison of 99mTc-HMPAO-labeled leukocyte scintigraphy findings with systemic inflammatory markers. J Med Palliat Care / JOMPAC / jompac. 2023 Aug. 1;4(4):329-35. doi:10.47582/jompac.1307746

TR DİZİN ULAKBİM and International Indexes (1d)

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
 


 

download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiVHJfSW5kZXhfbG9nby5wbmciLCJwYXRoIjoiN2EzMC84NTVhL2UyMWMvNjlkZjRkZmVhNTUyNTYuNzg3NjU2ODgucG5nIiwiZXhwIjoxNzc2MjQ1Nzc0LCJub25jZSI6IjU0MDZkMWE2NmE1Y2QwZTJjNGYyNDA1OTM2MTE0YWIxIn0.Tt-WScFXTj5r2jji5eDMFApNzujLMjMPl8ivXRbozSI



f9ab67f.png
asos-index.png


 


download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiQ3Jvc3NyZWYuanBnIiwicGF0aCI6IjAzMzEvMTdkZi8yN2ZkLzY5ZGY0ZThhMDZkMjg0LjQxMjAyNDg5LmpwZyIsImV4cCI6MTc3NjI0NTkxNCwibm9uY2UiOiI2NjM1Yjc5MWFiY2I1MDQ0NjkzMTAxMDhjY2Y2NzRlMCJ9.5jDQBEY-KErkDK1QjDmv9ichOkNIn5CWYibe1Wz1644
icmje_1_orig.png
 
cc.logo.large.png
 
ncbi.png
 
google-scholar.pngpn6krf5.jpg
 


 

Our journal is in TR-Dizin, DRJI (Directory of Research Journals Indexing, General Impact Factor, Google Scholar, Researchgate, CrossRef (DOI), ROAD, ASOS Index, Turk Medline Index, Eurasian Scientific Journal Index (ESJI), and Turkiye Citation Index.

EBSCO, DOAJ, OAJI and ProQuest Index are in process of evaluation. 

 

Journal articles are evaluated as "Double-Blind Peer Review"